About CAV Angels
CAV Angels, established in 2015, is an angel investment group based in Charlottesville, United States. It primarily focuses on Seed investments in companies in United States. Its portfolio includes 23 firms, spanning the HealthTech, Enterprise Applications sectors. Its most notable investments include companies like Contraline, MITO Materials and TearSolutions. As of Aug 2026, CAV Angels has witnessed 4 portfolio exits. Its latest investment was a Undisclosed Angel round in Avant Genomics on Jun 05, 2026, which also saw participation from TitletownTech and Vipc.
To date, 38 investors have co-invested in CAV Angels's portfolio companies, including prominent names like TitletownTech.
Key Metrics
Founded Year
2015
Location
Charlottesville, United States
Portfolio Companies
Sectors of Investment
Stages of Investment
Seed & Series A
Locations of Investment
CAV Angels' List of Top Investments
CAV Angels has a portfolio of 23 companies. Their most notable investments are in TeamGo and ARtGlass.Their portfolio spans across United States and Poland. They have invested in HealthTech, Enterprise Applications, High Tech and 13 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by CAV Angels:1. Contraline
Developer of a male contraceptive hydrogel device. The ADAM is a non-surgical, non-hormonal, and reversible birth control for men. It isultrasound-visible polymer solution that is injected into the vas deferens. Echo-V& forms a hydrogel device that acts as a semi-permeable membrane, blocking sperm while allowing fluids through.
Key facts about Contraline
- Founded Year: 2015
- Location: Charlottesville (United States)
- Stage: Series B
- Total Funding till date: $111M
- Investors: BVF Partners, TR Ventures and 36 Others
- Latest Funding Round: Series B, Jun 02, 2026, $*****
- Highlight: Editors' Pick
Manufacturer of hybrid polymer modifiers. They offer micron-sized hybridized graphene oxide and an epoxide POSS. These can increase durability, shed weight, and boost performance. These can be incorporated via dry powder and a shear dispersion and masterbatch in the polymer system. The products can be used in ester resins, Bisphenol A and Bisphenol F epoxies, and thermoplastics.
Key facts about MITO Materials
- Founded Year: 2018
- Location: Indianapolis (United States)
- Stage: Acquired
- Total Funding till date: $8.22M
- Employee Count: 5 as on Jul 31, 2026
- Investors: Elevate Ventures, Evergreen Climate Innovations and 12 Others
- Latest Funding Round: Seed, Jan 10, 2024, $*****
- Highlight: Acquired
TearSolutions develop topical therapeutics for the treatment of dry eye disease. Its lead product is a proprietary synthetic fragment of the protein lacritin. The company claims that Lacripep is equipotent with natural lacritin and can alleviate dry-eye symptoms for up to 16 hours. Its currently in phase I clinical trials.
Key facts about TearSolutions
- Founded Year: 2013
- Location: Charlottesville (United States)
- Stage: Series B
- Total Funding till date: $43M
- Employee Count: 10 as on Jul 31, 2026
- Investors: Center for Innovative Technology, VTC Ventures and 5 Others
- Latest Funding Round: Series B, Oct 29, 2025, $*****
- Highlight: Editors' Pick
AI-based 3D analyses of muscle for precision medicine. The company has developed software that assists doctors in analysis injuries and detecting MRI images for any muscle problem. It has features for injury management, performance optimization, and treatment.
Key facts about Springbok Analytics
- Founded Year: 2013
- Location: Charlottesville (United States)
- Stage: Series A
- Total Funding till date: $8M
- Employee Count: 40 as on Jul 31, 2026
- Investors: TitletownTech, NBA and 9 Others
- Latest Funding Round: Series A, Jan 24, 2025, $*****
- Highlight: Editors' Pick

5. Luminoah
Provider of portable feeding system to track feeding and remote monitoring. The company offers a wearable system a digital medical device designed for the enteral feeding market that combines durable medical equipment and consumable nutrition pouches to track feeds on their smartphone. The system also enables doctors to monitor patients remotely.
Key facts about Luminoah
- Founded Year: 2020
- Location: Charlottesville (United States)
- Stage: Series A
- Total Funding till date: $6M
- Employee Count: 15 as on Jul 31, 2026
- Investors: Sands Capital, JHH vc and 5 Others
- Latest Funding Round: Series A, Jun 15, 2023, $*****
- Highlight: Editors' Pick
CAV Angels' Year-on-Year Investment Trends
CAV Angels has invested in 23 companies over the last 8 years, with an average of 1 new investment annually in the last 5 years. As of Jun 2026, it has made 2 investments in this year. Its most recent first time investment was in Avant Genomics and most recent follow-on round was in Avant Genomics.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 2 | 0 | 2 |
2022 | 2 | 0 | 2 |
2021 | 2 | 1 | 3 |
2020 | 4 | 0 | 4 |
2019 | 0 | 0 | 0 |
2018 | 1 | 0 | 1 |
CAV Angels' Investments by Stage
CAV Angels has made 9 investments in Seed stage with an average round size of $2.42M and 3 investments in Series A stage with an average round size of $5.5M.Stage of entry | No. of Investments |
|---|---|
Seed | 9 |
Series A | 3 |
Note: We have considered here, only first round of investments
CAV Angels' Investments by Sector
CAV Angels has a diverse portfolio, with companies operating in the High Tech, Enterprise Applications, Consumer, HealthTech and Sustainability Tech. Notably, it has invested in 21 Tech companies, 20 Enterprise (B2B) companies, 12 Software companies and at least 6 companies focusing on Saas.Sector | No. of Investments |
|---|---|
High Tech | 5 |
Enterprise Applications | 3 |
Consumer | 2 |
HealthTech | 2 |
Sustainability Tech | 2 |
Others | 11 |
Note: We have considered here, only first round of investments
CAV Angels' Investments by Geography
CAV Angels has made most investments in United States (12).CAV Angels' recent investments
CAV Angels has made 2 investments in 2026 so far - Avant Genomics and Avant Genomics.Here are the most recent investments by CAV Angels:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 05, 2026 | United States | Angel | 4789 | [+2] | |
May 13, 2026 | United States | Seed | 4175 | [+2] | |
Jun 15, 2023 | United States | Series A | 2588 | [+3] | |
Apr 25, 2023 | United States | Seed | 1048 | ||
Sep 28, 2022 | United States | Seed | 8427 | [+6] |
Acquired companies in CAV Angels' Portfolio
4 companies from CAV Angels' portfolio have been acquired. The most recent acquisition was MITO Materials in Jun 2026 by First Graphene for $*****.Here are CAV Angels' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 25, 2026 | Aug 31, 2020 | Seed | 9585 | |
Feb 20, 2024 | Jul 21, 2022 | Series A | 6345 | |
Feb 02, 2022 | Dec 21, 2020 | Series A | 3531 | |
Dec 31, 2020 | - | - | 5467 |
Co-investors of CAV Angels
Over the past 8 years, 60 investors have co-invested in CAV Angels's portfolio companies. This includes funds and angels.
- Invested before CAV Angels: Lighthouse Labs, America’s Seed Fund and 8 others have invested in rounds before CAV Angels. There are 3 companies where Lighthouse Labs has invested before CAV Angels and 2 companies where America’s Seed Fund has invested before CAV Angels.
- Top Co-investors of CAV Angels: 38 investors entered a company along with CAV Angels. These include investors like TitletownTech (2 companies).
- Invested after CAV Angels: A total of 12 investors have invested in CAV Angels's portfolio after their investments. Top Investors include Ingevity (1 company) and SBIR (1 company).
Recent News related to CAV Angels
•
Avant Genomics has raised $3,500,000.00 in new Fundingintelligence360•Jun 05, 2026•Avant Genomics, CAV Angels, TitletownTech
•
Avant Genomics Raises $3M+ in FundingFinSMEs•May 13, 2026•VIPC, Global Good Fund, TitletownTech, CAV Angels
•
CAV Angels taps Richmond VC as its new boardThe Business Journals•Jan 18, 2024•CAV Angels, New Richmond Ventures
•
University of Virginia investment group puts money into 3 startupsThe Business Journals•Jan 11, 2024•CAV Angels, Clockwork, Alfie, One Health Group
•
Luminoah’s quest to reinvent tube feeding attracts new fundingTechCrunch+•Jun 15, 2023•Luminoah, Fry’s Path Capital, Sands Capital, CAV Angels and 2 others
•
Female-Founded CarpeDM Raises Over $1 millionGlobal Dating Insights•Sep 29, 2022•Carpe Diem Social, Elevate Capital, VIPC, Conscious Venture Lab and 7 others
•
CarpeDM Closes $1.054M Pre-Seed FundingFinSMEs•Sep 29, 2022•Carpe Diem Social, Elevate Capital, VIPC, Conscious Venture Lab and 5 others
•
Charlottesville's Astraea looks to scale up with new fundingThe Business Journals•Aug 23, 2022•Astraea, Aligned Climate Capital, CAV Angels, VeroBeach.com and 1 other
•
Satellite Intelligence Company Astraea Secures $6.5M Series A FundingNewswire•Jul 21, 2022•Astraea, Aligned Climate Capital, Drawdown, CAV Angels and 3 others
•
Social Start-Up Go Eyes US Expansion After Successful New Zealand LaunchBusiness Wire•May 04, 2021•TeamGo, CAV Angels
_1549372365678.png?format=webp&height=120&width=120)
